CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZNCF

carboplatin AUC 2/paclitaxel

Phase 2
ASTRAZENECA PLC (AZNCF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '26
AZNCFPhase 2

carboplatin AUC 2/paclitaxel Phase 2 Est. Readout

carboplatin AUC 2/paclitaxel
Nov 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Esophageal Adenocarcinoma

View Full Landscape
Drug Information

Target Indication

Esophageal Adenocarcinoma

Clinical Trial

NCT02962063

Last updated: 9/5/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.